- Latvia
- Our innovation
Our innovation
We are actively developing treatments for patients in five important therapeutic areas of healthcare: Cardiovascular & Metabolic diseases, Immunology, Infectious diseases & vaccines, Neuroscience and Oncology. Through extensive medical research our solutions may be able to alleviate, contain or cure some of the world’s most serious conditions and diseases.
Advancing science for the benefit of patients
The human body is vulnerable
The need for new and even more effective drugs is greater than ever. But there is also a need for preventive treatments for diseases, diagnostics to discover diseases at the earliest stage possible, and biomarkers to distinguish between the various sub-types of a disease.
Smart drug delivery
Forgetting to take your pills can affect how well they work. Recent advances in drug delivery are helping to overcome this problem. Medicines that slowly release their drug over 24 or even 72 hours can transform the lives of patients because they don’t have to remember to take multiple tablets daily to stop their symptoms from returning.
Personalized treatment
Which medicine works best for you? In the future we could possibly use biomarkers in your blood to catch your illness at the earliest possible stage. Our knowledge about diseases (precise causes and specific sub-types) and genes is growing every day. Based on the diagnosis of your specific disease and your unique genetic profile, we might then be able to tailor the medicines that will be most effective for you.
Every patient is unique and deserves a personalized approach. Take for example ‘intelligent’ forms of administration which increase a patient’s comfort and therapy adherence, for example, drugs with prolonged action.
Every patient is unique and deserves a personalized approach. Take for example ‘intelligent’ forms of administration which increase a patient’s comfort and therapy adherence, for example, drugs with prolonged action.
Our areas of research
Janssen helps to shape the research landscape by investing in outstanding research competencies in the areas of genome science, biotechnology, biomarkers, personalised diagnosis and vaccine platforms. We have early stage access to groundbreaking innovations in all hotspots across the globe. We embrace the most promising science and encourage collaboration in order to be able to discover and continually develop better, more advanced medication.
Focus on complex medical challenges
Our efforts are mainly focused on a number of the most distressing disorders and most complex medical challenges of our time. To achieve this we bring together top scientists and researchers in our five therapeutic domains.
Focus on complex medical challenges
Our efforts are mainly focused on a number of the most distressing disorders and most complex medical challenges of our time. To achieve this we bring together top scientists and researchers in our five therapeutic domains.
Neurosciences
Neurosciences deal with various psychiatric and neurological disorders such as psychoses, mood disorders, dementia, pain, schizophrenia and Alzheimer’s disease. A tradition of research dating back more than 60 years and a range of successful drugs have made Janssen a leading authority in this domain. Nevertheless, medical needs continue to dominate not least because of rapidly ageing.
Oncology
Oncology deals with everything related to research into and treatment of cancer. Cancer occurs in many different forms and types, which means that there is no single solution or treatment available. Janssen specializes in the treatment of breast cancer, lung cancer, prostate cancer, blood cancers and bowel cancer. Our ultimate goal is to make cancer a preventable, chronic or eventually curable disease.
Infectious Diseases & Vaccines
Immunology
We have a rich history in the development of medicines to combat immunological disorders. Immunology is the branch of science that focuses on research into the immune system. We continue to augment our expertise through expansion of our pipeline of innovative products for the treatment of complex immunological diseases such as rheumatoid arthritis,IBS (‘irritable bowel syndrome’), ulcerative colitis and psoriasis.
Cardiovascular & Metabolic Diseases
Cardiovascular diseases, diabetes and obesity are a growing medical challenge in the 21st century that are aggravated by poor eating habits and an unhealthy lifestyle. Expenditure on, for example, cardiovascular disease is costing the EU 192 billion euro per annum. Janssen also focuses on this specific research field in order to offer innovative solutions to people suffering from such diseases.
Learn more about our innovation
Research & Development at Janssen: innovations which lead to better insights into diseases
